New Study Recognizes Mercury-Autism Biomarkers
According to a recent press release by the Coalition for Mercury-Free Drugs (mercury-freedrugs.org), “A Prospective Study of Transsulfuration Biomarkers in Autistic Disorders,” published in Neurochemical Research (July 2008), recognizes mercury susceptibility markers in patients diagnosed with an autistic spectrum disorder (ASD).
The study evaluated a number of children diagnosed with an ASD. After examining transsulfuration metabolites, the investigators concluded that the patients diagnosed with an ASD showed signs of increased oxidative stress and a decreased detoxification capacity, particularly for mercury. Because routine, clinically available lab testing was used in the study, the researchers suggest making this procedure a standard part of the diagnostic process.
Download the study for more information: www.usautism.org